Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.

Jingru YuErle RefsumLise M HelsingenTrine FolseraasAlexander PlonerPaulina WieszczyIshita BaruaHenriette C JodalEspen MelumMagnus LøbergJohannes BlomMichael BretthauerHans-Olov AdamiMette KalagerWeimin Ye

Published in: United European gastroenterology journal (2022)

The dramatically increased risks of hepato-pancreato-biliary cancers in PSC-IBD patients support periodic surveillance for these malignancies. While much lower, the excess relative risks in non-PSC-IBD patients were not trivial compared to non-IBD related risk factors.

Keyphrases

end stage renal disease
risk factors
ejection fraction
newly diagnosed
prognostic factors
public health
squamous cell carcinoma
patient reported outcomes
papillary thyroid